| abstract |
A pharmaceutically acceptable crystalline addition salt which is one of trans-4 - ((3- (2-chloro-4 - (((2R) -2-hydroxy-2-) hydroxy (di-2-thienyl) ethanedisulfonate) (8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl) ethylamino) methyl) -5-methoxyphenylamino) -3-oxopropyl) methyl) amino) -cyclohexyl, 2-hydroxy-2,2- discarinate di (thiophen-2-yl) trans-4 acetate - ((2- (2-chloro-4 - (((R) -2-hydroxy-2- (8-hydroxy-2-oxo-1,2- dihydroquinolin-5-yl) ethylamino) -methyl) -5-methoxyphenyl-carbamoyloxy) ethyl) - (methyl) amino) -cyclohexyl and 2-hydroxy-2,2-di (thiophene-2-yl) acetate L-tartrate of trans-4 - ((2- (2-chloro-4 - (((R) -2-hydroxy-2- (8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl) ethylamino) - methyl) -5-methoxyphenylcarbamoyloxy) ethyl) - (methyl) amino) cyclohexyl, or a pharmaceutically acceptable solvate thereof. |